Heart Disease Trial, Recruiting NCT06125392 Sponsor: Johannes Gutenberg University Mainz Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06125392
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had both blood pressure and blood flow measured inside at least one of their own (non-bypassed) heart arteries, tested using two different types of medications that cause the arteries to widen.

Who may not be able to join:

  • People whose blood pressure or circulation is unstable or not functioning normally at the time of the trial.
  • People who are under 18 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Johannes Gutenberg University Mainz
Registry
ClinicalTrials.gov
Start date
30 September 2023
Est. completion
31 August 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Identification of endotypes of coronary vasomotor function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov